CTRI/2012/05/002651尚未招募未知
Evaluation of Immunological Markers for monitoring of Neonatal sepsis.
BECTION DICKINSON AND COMPANY0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Term or Pre-term neonates (born at greater than 28 weeks gestation) admitted to neonatal intensive care units, presenting with signs and symptoms suggestive of systemic infection and requiring a full sepsis evaluation and antibiotic treatment will be eligible for inclusion in the study irrespective of their birth weight and postnatal age.
排除标准
- •Patients who were already receiving parenteral antibiotics at time of initial sepsis evaluation will be excluded
研究者
相似试验
已完成
不适用
Immunological monitoring and assessment of biomarkers predictive of clinical response to first-line treatment with bosutinib or imatinib in chronic phase chronic myeloid leukemiaChronic myeloid leukemiaCML10024324NL-OMON42791Vrije Universiteit Medisch Centrum5
尚未招募
不适用
Immunohematogical markers in Graves diseaseCTRI/2021/12/038899Jayanthy Ramesh
招募中
不适用
Detection of markers for immune pathophysiology and analysis of their prognostic value in patients with chronic thrombocytopenia without an increase in the number of bone marrow megakaryocytes: a prospective observation study.Pancytopenia, thrombocytopeniaJPRN-UMIN000002729Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science.50
进行中（未招募）
1 期
Monitoring response on COVID-19 vaccination in children with cancerChildren with cancer, receiving COVID-19 vaccinationEUCTR2021-003388-90-NLPrincess Máxima Center for Pediatric Oncology130
已完成
4 期
Prospective monitoring of immune response following COVID-19 vaccination in children with cancerNL-OMON52106Prinses Máxima Centrum voor Kinderoncologie130